- Home
- MNRO vs HQL Comparison
MNRO vs HQL Comparison
Compare MNRO & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNRO | HQL |
|---|---|---|
| Founded | 1957 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 501.0M | 507.9M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNRO | HQL |
|---|---|---|
| Price | $16.59 | $17.82 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 777.4K | 106.9K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | 6.66% | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.26 | ★ 0.79 |
| Revenue | ★ $1,195,334,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.59 | N/A |
| P/E Ratio | $64.73 | ★ $22.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.20 | $11.72 |
| 52 Week High | $23.91 | $17.85 |
Technical Indicators
Market Signals| Indicator | MNRO | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 68.50 |
| Support Level | $16.19 | $16.40 |
| Resistance Level | $16.74 | N/A |
| Average True Range (ATR) | 0.63 | 0.36 |
| MACD | 0.29 | 0.15 |
| Stochastic Oscillator | 74.45 | 93.46 |
Price Performance
Historical ComparisonAbout MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.